1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,325 | 2,625 | 19.01. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.12.25 | Q-Linea AB: Q-linea signs first distribution agreement in South Asia | 266 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA today announces the signing of its first distribution agreement in South Asia, marking an important milestone in the company's global expansion strategy. The agreement... ► Artikel lesen | |
| 23.12.25 | Q-Linea AB: Q-linea announces first two US hospital systems' clinical implementation of ASTar | 126 | GlobeNewswire (Europe) | Q-linea AB (Publ) (OMX: QLINEA) announces the clinical implementation of the first US ASTar instruments at UI (University of Iowa) Health Care and a large healthcare system in Texas. UI Health Care... ► Artikel lesen | |
| 20.11.25 | Q-Linea AB: Q-linea announces new organisation and changes in executive leadership team | 279 | GlobeNewswire (Europe) | Q-linea AB (publ) (Nasdaq Stockholm: QLINEA) today announces that it has reached agreement with all relevant unions regarding the company's new organisation. As part of these changes, Ylva Molin has... ► Artikel lesen | |
| 18.11.25 | Q-Linea AB: Q-linea announces FDA submission for expanded claims for ASTar BC G- panel | 525 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today announces their FDA 510(k) submission for expanded organism and antimicrobial claims on their ASTar BC G- panel, improving the clinical utility of the panel for... ► Artikel lesen | |
| 11.11.25 | Q-Linea AB: Q-linea announces outcome of rights issue | 135 | GlobeNewswire (Europe) | Q-linea AB (publ) ("Q-linea" or the "Company") (Nasdaq Stockholm: QLINEA) announces the outcome of the Company's rights issue of approximately SEK 322 (the "Rights Issue"), for which the subscription... ► Artikel lesen | |
| 24.10.25 | Listing of subscription rights and paid subscription shares of Q-Linea AB | 269 | GlobeNewswire | With effect from October 27, 2025, the subscription rights of Q-Linea AB will be traded on the list for Equity rights. Trading will continue up until and including November 05, 2025.
Instrument:
Subscription... ► Artikel lesen | |
| 22.10.25 | Q-Linea AB: Q-linea announces cost efficiency program to accelerate sales and marketing activities | 190 | GlobeNewswire (Europe) | Driven by Q-linea's strong commercial progression with a growing customer base, Q-linea today announced a cost efficiency program to optimise the organisation and cost structure to meet the increasing... ► Artikel lesen | |
| Q-LINEA Aktie jetzt für 0€ handeln | |||||
| 21.10.25 | Q-Linea AB: Bulletin from Extraordinary General Meeting in Q-Linea AB (publ) | 163 | GlobeNewswire (Europe) | The extraordinary general meeting of Q-linea AB (publ) (the "Company"), org.nr. 556729-0217, was held on October 21, 2025 in Uppsala, Sweden, at which the shareholders primarily resolved as follows.... ► Artikel lesen | |
| 21.10.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 21.10.2025 | 211 | Xetra Newsboard | Das Instrument 3F80 SE0025420714 Q-LINEA AB EQUITY wird cum Kapitalmassnahme gehandelt am 21.10.2025 und ex Kapitalmassnahme am 22.10.2025 The instrument 3F80 SE0025420714 Q-LINEA AB EQUITY is traded... ► Artikel lesen | |
| 20.10.25 | Earnings Call Transkript: Q-linea erzielt starkes Wachstum bei wiederkehrenden Einnahmen im 3. Quartal 2025 | 3 | Investing.com Deutsch | ||
| 20.10.25 | Q-linea Q3 2025: Rekordnachfrage bei Verbrauchsmaterialien treibt globale Expansion an | 4 | Investing.com Deutsch | ||
| 20.10.25 | Q-Linea AB: Interim report 1 January - 30 September 2025 | 164 | GlobeNewswire (Europe) | Strong pipeline growth while the installed base of ASTar increases demand for consumables
The quarter July - September 2025Net sales amounted to SEK 3.5 (0.6) million.Operating result (EBIT) of SEK... ► Artikel lesen | |
| 19.10.25 | Q-Linea AB: Stuart Gander appointed CEO and Anders Ljunggren appointed deputy CEO of Q-linea AB | 133 | GlobeNewswire (Europe) | The board of directors of Q-linea AB (publ) has today appointed Stuart Gander as CEO of the company. Former CEO Anders Ljunggren continues as deputy CEO of the company.
Since March 1, 2024, Stuart Gander... ► Artikel lesen | |
| 03.10.25 | Q-Linea AB: US Trauma Center signs commercial contract | 275 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) announces adoption of the first Accelerate Pheno conversion to the ASTar system by a prominent US level 1 University Hospital Trauma Center.
The University hospital selected... ► Artikel lesen | |
| 18.09.25 | Q-Linea AB: Q-linea | Letter from the CEO | 199 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today shared a Company update.
Key messagesReiterating target of 30 - 40 ASTar units contracted by end of year 2025 with outlook for 100 - 120 by end of 2026 and exceeding... ► Artikel lesen | |
| 18.09.25 | Q-Linea AB: Q-linea resolves to carry out a rights issue of approximately SEK 322 million and announces terms | 279 | GlobeNewswire (Europe) | Q-linea AB (publ) ("Q-linea" or the "Company") (Nasdaq Stockholm: QLINEA), announces that the board of directors today has resolved to carry out a share issue of approximately SEK 322 million with preferential... ► Artikel lesen | |
| 05.09.25 | Q-Linea AB: Q-linea to initiate new clinical evaluations of ASTar in the GCC region | 412 | GlobeNewswire (Europe) | Q-linea AB (Publ) (OMX: QLINEA) announces 2 new clinical evaluations of ASTar in Saudi Arabia and Kuwait.
Q-linea, through the distributor partner AMICO Group, is moving into clinical evaluation of... ► Artikel lesen | |
| 14.07.25 | XFRA NEW INSTRUMENTS AVAILABLE ON 14.07.2025 | 597 | Xetra Newsboard | The following instruments on XETRA do have their first trading 14.07.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 14.07.2025
Aktien
1 PLK2ITR00010 Fabrity S.A.
2 SE0013512506... ► Artikel lesen | |
| 11.07.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 11.07.2025 | 588 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 11.07.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 11.07.2025ISIN NameCA1394811055 CAPE... ► Artikel lesen | |
| 11.07.25 | XFRA ISIN CHANGE | 434 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS52110H1005 Lazydays Holdings Inc. 11.07.2025 US52110H2094 Lazydays Holdings Inc. 14.07.2025 Tausch 30:1US08862L1035 Beyond... ► Artikel lesen |
1 2 Weiter >>
33 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,370 | -0,92 % | Aktien Frankfurt: Dax setzt Rekordrally mit kleinem Schrittchen fort | FRANKFURT (dpa-AFX) - Der Dax hat am Montag nach einem zunächst stabilen Börsenauftakt an seinen zum Jahresbeginn wieder aufgenommenen Rekordlauf angeknüpft. Um die Mittagszeit legte der deutsche Leitindex... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,100 | -0,99 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung gemäß Artikel 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014 und Artikel 2 Abs. 1 der Delegierten... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 37,520 | -4,87 % | Bechtle, Carl Zeiss Meditec, CTS Eventim, MTU Aero Engines, Suss MicroTec, TeamViewer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| DRAEGERWERK | 92,00 | +2,56 % | Draegerwerk AG & Co. KGaA: Fokus auf die Bewertung: Kursziel erreicht. Von KAUFEN auf HALTEN. | Die Aktien von Drägerwerk (Dräger) sind seit Beginn des Jahres 2026 um nahezu 10% gestiegen, was den Kurs der Aktie nahe an unser Kursziel von 76,00 EUR bringt und eine Herabstufung von "Kaufen" auf... ► Artikel lesen | |
| MEDTRONIC | 83,06 | -0,74 % | Medtronic Receives FDA Clearance For MiniMed Go Smart MDI Diabetes App | WASHINGTON (dpa-AFX) - Medtronic (MDT), a medical device company, on Monday announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its MiniMed Go app. This... ► Artikel lesen | |
| INTUITIVE SURGICAL | 454,00 | +0,32 % | Intuitive Surgical, Inc.: Intuitive Announces Preliminary Fourth Quarter and Full Year 2025 Results | SUNNYVALE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today... ► Artikel lesen | |
| THERMO FISHER | 521,20 | -0,59 % | EQS-News: TetraScience kündigt Zusammenarbeit mit Thermo Fisher Scientific an, um wissenschaftliche Daten und KI-Fähigkeiten im Labor zu beschleunigen | EQS-News: TetraScience
/ Schlagwort(e): Vertrag
TetraScience kündigt Zusammenarbeit mit Thermo Fisher Scientific an, um wissenschaftliche Daten und KI-Fähigkeiten im Labor zu... ► Artikel lesen | |
| TELADOC HEALTH | 5,621 | +2,37 % | Teladoc Health Unveils New Capabilities to Treat More Conditions and Detect Care Gaps Earlier | ||
| ROKU | 87,88 | -0,50 % | Pinterest Adds Shoppable TV With Roku Partnership | ||
| HIMS & HERS HEALTH | 26,090 | +0,35 % | Hims & Hers Expands Platform-Led Access to Digital Healthcare | ||
| SERNOVA BIOTHERAPEUTICS | 0,097 | +2,65 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| DEXCOM | 58,36 | -0,15 % | DexCom Stock Declines Following Strong Preliminary Q4 Results | ||
| ALCON | 66,00 | +0,12 % | Staar Surgical CEO, board chair stepping down after Alcon merger fails | ||
| VENUS CONCEPT | 7,940 | +455,24 % | Venus Concept Stock Explodes Over 500% After Major Investor Takes Control | ||
| ALIGNMENT HEALTHCARE | 22,500 | 0,00 % | Alignment Healthcare Reports 31% Year-Over-Year Membership Growth to 275,300 as of Jan. 1, 2026 | Guides year-end 2026 health plan membership range of 290,000 to 296,000. Announces its expectation that consensus adjusted EBITDA of approximately $145 million in 2026 will be within its full-year... ► Artikel lesen |
Q-LINEA AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,010 (-0,41 %) liegt der Kurs bei 2,400 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu Q-LINEA AB finden Sie auf Wallstreet Online.